First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin (Q39814748)

14 September 2017

First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin (English)

1 reference

14 September 2017

6

N Guiso

1 reference

14 September 2017

V Bouchez

1

1 reference

14 September 2017

D Brun

2

1 reference

14 September 2017

T Cantinelli

3

1 reference

14 September 2017

G Dore

4

1 reference

14 September 2017

E Njamkepo

5

1 reference

14 September 2017

language of work or name

English

0 references

publication date

8 August 2009

1 reference

14 September 2017

1 reference

14 September 2017

27

1 reference

14 September 2017

43

1 reference

14 September 2017

6034-6041

1 reference

Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination

14 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Transmission of Bordetella pertussis to young infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Pertussis of adults and infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Study of the risk factors for severe childhood pertussis based on hospital surveillance data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Temporal analysis of French Bordetella pertussis isolates by comparative whole-genome hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Genomic analysis and comparison of Bordetella pertussis isolates circulating in low and high vaccine coverage areas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Fimbrial typing of Bordetello pertussis isolates: agglutination with polyclonal and monoclonal antisera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Is the Sequenced Bordetella pertussis strain Tohama I representative of the species?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Multilocus sequence typing of Bordetella pertussis based on surface protein genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Significant gene order and expression differences in Bordetella pertussis despite limited gene content variation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Bordetella species are distinguished by patterns of substantial gene loss and host adaptation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Comparative genomics of Bordetella pertussis reveals progressive gene loss in Finnish strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Genomic changes following host restriction in bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Extensive proliferation of transposable elements in heritable bacterial symbionts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Polymorphism of repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.074

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2009.07.074

1 reference

14 September 2017

1 reference